United States Lidocaine Patches Market Size

U.S. Lidocaine Patch Market

Introduction
1. Study Objective
2. Scope of the report
3. Market Taxonomy
Study Assumptions and Abbreviations
1. Research Methodology
2. Secondary Research
3. Primary Research
4. SPSS Approach
5. Data Triangulation
Executive Summary
U.S. Industry Overview
1. Market Overview
2. Industry Supply Chain Analysis
3. DROTs
  1. Driver
  2. Restraint
  3. Opportunities
  4. Trends
4. Government Regulation: How they would Aid the Business?
5. Competitive Landscape
  1. Amneal Pharmaceuticals LLC
  2. Endo Pharmaceuticals Inc
  3. Hisamitsu America, Inc.
  4. Medline Industries, LP.
  5. Scilex Pharmaceuticals Inc.
  6. Sparsha Pharma USA
  7. Teikoku Pharma
  8. Teva Pharmaceuticals USA, Inc.
  9. Viatris Inc.
  10. YARAL Pharma Inc.
6. Technology Analysis
7. Reimbursement Trends in the Lidocaine Patches Industry
8. Startup Analysis
9. Ongoing Technological Advancements
10. SWOT Analysis
11. Price Benchmarking
12. Pain Patch Market: Key Products And Future Outlook
13. Strategic Pathways For Success in the US Lidocaine Patches Market
14. Pipeline Analysis of Lidocaine Patches in the US
15. Epidemiological Overview Of Diseases Treated With Lidocaine Patches
16. Wholesale Acquisition Cost Sale Analysis
17. Factors Influencing The Price Changes
18. Root Cause Analysis
19. PESTLE Analysis
20. Porter Five Forces Analysis
21. Industry Risk
U.S. Outlook and Projections
1. Overview
  1. Market Value (USD Million), Volume (Million Units) and Current and Future Projections, 2024-2034
  2. Increment $ Opportunity Assessment, 2024-2034
  3. Year-on-Year Growth Forecast (%)
2. Segmentation (USD Million), 2024-2034, By
  1. Type, Value (USD Million), Volume (Million Units)
    1. Prescription Medicines
    2. OTC Medicines
  2. End user, Value (USD Million)
    1. Hospital Pharmacies
    2. Drug Stores and Retail Pharmacies
    3. Online Providers
  3. Region, Value (USD million)
    1. Northeast
    2. Southeast
    3. Midwest
    4. Southwest
    5. West
Northeast Market
1. Overview
  1. Market Value (USD Million), Volume (Million Units) and Current and Future Projections, 2024-2034
  2. Increment $ Opportunity Assessment, 2024-2034
  3. Year-on-Year Growth Forecast (%)
2. Segmentation (USD Million), 2024-2034, By
  1. Type, Value (USD Million), Volume (Million Units)
    1. Prescription Medicines
    2. OTC Medicines
  2. End user, Value (USD Million)
    1. Hospital Pharmacies
    2. Drug Stores and Retail Pharmacies
    3. Online Providers
Southeast Market
1. Overview
  1. Market Value (USD Million), Volume (Million Units) and Current and Future Projections, 2024-2034
  2. Increment $ Opportunity Assessment, 2024-2034
  3. Year-on-Year Growth Forecast (%)
2. Segmentation (USD Million), 2024-2034, By
  1. Type, Value (USD Million), Volume (Million Units)
    1. Prescription Medicines
    2. OTC Medicines
  2. End user, Value (USD Million)
    1. Hospital Pharmacies
    2. Drug Stores and Retail Pharmacies
    3. Online Providers
Midwest Market
1. Overview
  1. Market Value (USD Million), Volume (Million Units) and Current and Future Projections, 2024-2034
  2. Increment $ Opportunity Assessment, 2024-2034
  3. Year-on-Year Growth Forecast (%)
2. Segmentation (USD Million), 2024-2034, By
  1. Type, Value (USD Million), Volume (Million Units)
    1. Prescription Medicines
    2. OTC Medicines
  2. End user, Value (USD Million)
    1. Hospital Pharmacies
    2. Drug Stores and Retail Pharmacies
    3. Online Providers
Southwest Market
1. Overview
  1. Market Value (USD Million), Volume (Million Units) and Current and Future Projections, 2024-2034
  2. Increment $ Opportunity Assessment, 2024-2034
  3. Year-on-Year Growth Forecast (%)
2. Segmentation (USD Million), By
  1. Type, Value (USD Million), Volume (Million Units)
    1. Prescription Medicines
    2. OTC Medicines
  2. End user, Value (USD Million)
    1. Hospital Pharmacies
    2. Drug Stores and Retail Pharmacies
    3. Online Providers
West Market
1. Overview
  1. Market Value (USD Million), Volume (Million Units) and Current and Future Projections, 2024-2034
  2. Increment $ Opportunity Assessment, 2024-2034
  3. Year-on-Year Growth Forecast (%)
2. Segmentation (USD Million), By
  1. Type, Value (USD Million), Volume (Million Units)
    1. Prescription Medicines
    2. OTC Medicines
  2. End user, Value (USD Million)
    1. Hospital Pharmacies
    2. Drug Stores and Retail Pharmacies
    3. Online Providers
Global Economic Scenario
1. World Economic Outlook
About Research Nester
1. Our Global Clientele
2. We Serve Clients Across World

United States Lidocaine Patches Market Size

U.S. Lidocaine Patches Market size was valued at USD 560.7 million in 2024 and is projected to reach a valuation of USD 963 million by the end of 2034, rising at a CAGR of 5.5% during the forecast period, i.e., 2025-2034. In 2025, the industry size of U.S. lidocaine patches is assessed at USD 591.2 million.

The U.S. lidocaine patches market is witnessing expansion due to an aging population and a growing demand for non-opioid pain management solutions. This aging population is indicative of the growing demand for targeted pain therapies like lidocaine patches. For instance, in February 2024, Scilex Holding Company announced that its flagship product, ZTlido, has more than one million users. Such advancements reinforce the growing adoption of lidocaine patches for safe, localized pain relief. Government healthcare initiatives on palliative care and pain management also further drive market growth.

The United States lidocaine patches market is evolving with innovative product developments that are offering superior pain relief options to the consumer. Hisamitsu America introduced the Salonpas Pain Relieving FLEX Patch Lidocaine 4% in June 2022, characterized by superior flexibility for improved wearability. These developments are a response to the increasing burden of chronic diseases, including arthritis and cancer, for which palliative care solutions are imperative. Moreover, government-supported programs aimed at substituting opioids with other painkillers reflect a general approach to the problem of opioid addiction and, thus, accelerate the demand for lidocaine patches in the U.S.

Frequently Asked Questions (FAQ)

In 2024, the industry size of U.S. lidocaine patch was USD 560.7 million.

The U.S. lidocaine patch market size was USD 560.7 million in 2024 and is expected to reach USD 963 million by the end of 2034, expanding at a CAGR of 5.5% during the forecast period, i.e., 2025-2034. In 2025, the industry size of U.S. lidocaine patch will be valued at USD 591.2 million.

Key players in the market are Amneal Pharmaceuticals LLC, Endo Pharmaceuticals Inc, Hisamitsu America, Inc., Medline Industries, LP., Scilex Pharmaceuticals Inc., Sparsha Pharma USA, Teikoku Pharma, Teva Pharmaceuticals USA, Inc., Viatris Inc., YARAL Pharma Inc.

The prescription medicines segment is anticipated to lead the U.S. lidocaine patch market during the forecast period.

Southeast U.S. is likely to offer lucrative prospects to the companies in market during the forecast period.

United States Lidocaine Patches Market Size

United States Lidocaine Patches Market Size

Browse Key Market Insights with Data Illustration:

Frequently Asked Questions (FAQ)

Subscribe to Our Newsletters

United States Lidocaine Patches Market Size

United States Lidocaine Patches Market Size

Browse Key Market Insights with Data Illustration:

Frequently Asked Questions (FAQ)

How big is the U.S. lidocaine patches industry?

What is the outlook for the U.S. lidocaine patches market?

Who are the major players dominating the U.S. lidocaine patches landscape?

Which segment will capture the significant market share for U.S. lidocaine patches by 2034?

Which region will provide more opportunities for the U.S. lidocaine patches business in the coming years?